Denmark-headquartered Niro is finalizing a €10 million investment
programme centred on the expansion of its drying test site, located
at its main facility in Copenhagen, that will extend its reach into
the pharmaceutical sector, reports...
Pharmacogenomics will alter the balance of power in the way drugs
are developed, tested, marketed and prescribed during the next
decade, and the blockbuster business model of big pharmaceutical
companies will eventually give way...
A new high throughput ion channel screening service has been
launched by BioFocus, which will allow pharmaceutical companies to
pre-screen libraries against defined cell lines, identifying target
compounds and limiting the use of...
Genaissance Pharmaceuticals expansion of its genetic testing
service comes after it was revealed there are over 50 approved
drugs which prolong the QT interval potentially causing cardiac
arrythmias and safety concerns amongst effective...
Biotechnology company Mergen Limited has announced the launch of a
new service reselling DNA microarrays for gene expression analysis.
The service signals a cost effective approach to providing
custom-built microarrays to the market.
US biotechnology start-up Cytovance Biologics has officially opened
for business this month, offering a portfolio of process
development services to support biotechnology companies preparing
to progress products into clinical development.
The rapid growth in the development and commercialisation of new
biological entities (NBEs) has been one of the major trends in the
pharmaceutical sector over the last few years, but their production
can be said to be more of an art...
Tepnel announced it had completed the acquistion of Diaclone
Research adding customisable monoclonal antibodies (mABs),
complimentary reagents and ELISA test kits to its range of life
sciences instrumentation and services.